Citius Oncology (CTOR) Other Working Capital Changes (2023 - 2026)

Citius Oncology's Other Working Capital Changes history runs 4 years deep, the most recent figure standing at -$110553.0 for Q1 2026.

• In Q1 2026, Other Working Capital Changes changed N/A year-over-year to -$110553.0; the TTM figure through Mar 2026 stood at $4.0 million (changed N/A YoY), while the FY2024 annual figure was $1.1 million, down 78.19% from the prior year.
• Other Working Capital Changes was -$110553.0 for Q1 2026 at Citius Oncology, down from $1.8 million in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $2.3 million in Q2 2024 to a low of -$110553.0 in Q1 2026.
• Historically, Other Working Capital Changes has averaged $571820.6 across 4 years, with a median of $35610.0 in 2024.
• Biggest YoY gain for Other Working Capital Changes was 6947.67% in 2024; the steepest drop was 3.29% in 2024.
• A 4-year view of Other Working Capital Changes shows it stood at -$29536.0 in 2023, then soared by 7792.04% to $2.3 million in 2024, then fell by 19.38% to $1.8 million in 2025, then tumbled by 106.04% to -$110553.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$110553.0 (Q1 2026), $1.8 million (Q4 2025), and $2.3 million (Q2 2024), per Business Quant data.